Evidence map›Paper›PMID 27503641›Full record

ArticleAntimicrobial agents and chemotherapy2016

Development of an In Vitro Assay for Detection of Drug-Induced Resuscitation-Promoting-Factor-Dependent Mycobacteria.

Jessica Loraine, Feifei Pu, Obolbek Turapov, Galina V Mukamolova

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Dissecting rifampicin heteroresistance inJournal of medical microbiology · 2025
    Article
  2. Article
  3. Article
  4. Culture-Free Enumeration ofMicroorganisms · 2022
    Article
  5. Dimethyl fumarate eliminates differentially culturableFrontiers in cellular and infection microbiology · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. TheBioMed research international · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Rifamycin action on RNA polymerase in antibiotic-tolerantProceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jessica LoraineDepartment of Infection, Immunity, and Inflammation, University of Leicester, Leicester, United Kingdom.
Feifei PuDepartment of Infection, Immunity, and Inflammation, University of Leicester, Leicester, United Kingdom.
Obolbek TurapovDepartment of Infection, Immunity, and Inflammation, University of Leicester, Leicester, United Kingdom.
Galina V MukamolovaDepartment of Infection, Immunity, and Inflammation, University of Leicester, Leicester, United Kingdom gvm4@le.ac.uk.

Funding

Biotechnology and Biological Sciences Research Council BB/H008586/1Biotechnology and Biological Sciences Research Council BB/K000330/1
6 · The paper itself

Abstract

Tuberculosis is a major infectious disease that requires prolonged chemotherapy with a combination of four drugs. Here we present data suggesting that treatment of Mycobacterium tuberculosis, the causative agent of tuberculosis, and Mycobacterium smegmatis, a model organism widely used for the screening of antituberculosis agents, with first-line drugs resulted in the generation of substantial populations that could be recovered only by the addition of a culture supernatant from growing mycobacteria. These bacilli failed to grow in standard media, resulting in significant underestimation of the numbers of viable mycobacteria in treated samples. We generated M. smegmatis strains overexpressing M. tuberculosis resuscitation-promoting factors (Rpfs) and demonstrated their application for the detection of Rpf-dependent mycobacteria generated after drug exposure. Our data offer novel opportunities for validation of the sterilizing activity of antituberculosis agents.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsBacteriological TechniquesCulture MediaCytokinesGene Expression Regulation, BacterialMicrobial Sensitivity TestsMycobacterium smegmatisMycobacterium tuberculosisReproducibility of ResultsAnti-Bacterial AgentsBacterial ProteinsCulture MediaCytokinesresuscitation-promoting factor, bacteria

Identifiers

PMID27503641
PMCPMC5038329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.